IDEAYA Biosciences announces the latest development timeline for its Cdkn2a project
Show original
The company plans to determine its development candidate drug in the second half of 2026, followed by submitting a new drug clinical trial application in the first half of 2027. This progress marks the company's continued advancement in the field of tumor-targeted therapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$67,811.87
+0.41%
Ethereum
ETH
$1,994.88
+2.19%
Tether USDt
USDT
$0.9998
-0.02%
BNB
BNB
$627.23
+1.13%
XRP
XRP
$1.35
-0.62%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$83.67
+1.01%
TRON
TRX
$0.2855
-0.26%
Dogecoin
DOGE
$0.09045
+1.26%
Cardano
ADA
$0.2551
+0.12%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now